[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572036":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":35,"locations":40,"responsibleParty":54,"collaborators":25,"id":57,"slug":25,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":25,"eligibilityCriteria":62,"healthyVolunteers":58,"sex":63,"minAge":64,"maxAge":25,"enrollmentInfo":65,"targetDuration":25,"studyType":68,"phases":69,"briefSummary":71,"conditions":72,"keywords":76,"overallStatus":78,"whyStopped":25,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"West China Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"SiFICB Group","EXPERIMENTAL","Participants will receive an ultrasound-guided SiFICB above the inguinal ligament with 40 ml of 0.25% ropivacaine.",[13],"Other: supra-inguinal fascia iliaca compartment block",{"label":15,"type":16,"description":17,"interventionNames":18},"Tramadol Group","ACTIVE_COMPARATOR","Participants will receive intravenous tramadol at a dose of 2 mg\u002Fkg",[19],"Drug: Tramadol",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"supra-inguinal fascia iliaca compartment block","Supra-inguinal fascia iliaca compartment block with 40 ml of 0.25% ropivacaine",[9],null,{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":25},"DRUG","Tramadol","intravenous tramadol at a dose of 2 mg\u002Fkg",[15],[32],{"name":33,"affiliation":5,"role":34},"Ren Liao, M.D.","PRINCIPAL_INVESTIGATOR",[36],{"name":33,"role":37,"phone":38,"phoneExt":25,"email":39},"CONTACT","+86-18980602177","liaoren7733@163.com",[41],{"facility":42,"status":25,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":25},"West China Hospital, Sichuan University","Chengdu","Sichuan","610041","China","CN",{"type":49,"coordinates":50},"Point",[51,52],104.06667,30.66667,{"lat":52,"lon":51},{"type":34,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Ren Liao","Professor","100572036",false,"NCT06728033","Fascia Iliaca Compartment Block and Tramadol for Analgesia in Hip Fracture","Comparison of Perioperative Analgesic Effects of Preoperative Supra-inguinal Fascia Iliaca Compartment Block and Intravenous Tramadol in Hip Fracture: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients with a confirmed diagnosis of hip fracture\n* Aged \\>18 years, of any gender\n* Provide signed and dated written informed consent before formal enrollment in the study.\n\nExclusion Criteria:\n\n* Allergic to tramadol or ropivacaine\n* Unable to cooperate with the study for any reason, such as language comprehension issues, psychiatric disorders, severe hearing impairments, or communication barriers\n* Unsuitable for the trial by the investigator based on clinical judgment.","ALL","18 Years",{"count":66,"type":67},240,"ESTIMATED","INTERVENTIONAL",[70],"NA","Hip fractures are a growing public health concern globally due to the aging population, with high incidence and significant mortality rates one year post-fracture. Effective pain management is critical to improving outcomes and accelerating recovery. Tramadol, a widely used intravenous analgesic, has dual opioid and non-opioid mechanisms but is associated with side effects, such as nausea, dizziness, and respiratory depression, necessitating careful monitoring in hip fracture patients.\n\nThe supra-inguinal fascia iliaca compartment block (SiFICB) offers a promising alternative, targeting key nerves to achieve effective analgesia through ultrasound-guided delivery of local anesthetics. SiFICB minimizes side effects and improves pain control by accurately blocking the femoral, lateral femoral cutaneous, and obturator nerves. While its postoperative benefits are well-documented, its efficacy in managing preoperative pain from hip fractures remains underexplored.\n\nThis study hypothesizes that ultrasound-guided SiFICB provides superior perioperative analgesia compared to intravenous tramadol. A prospective randomized controlled trial will evaluate the analgesic efficacy of SiFICB, using the numerical rating scale (NRS) to assess pain, aiming to improve the management of hip fracture-related pain and patient outcomes.",[73,74,75],"Hip Fractures","Ultrasound-guided Nerve Block","Perioperative Analgesia",[73,77,28],"Supra-inguinal Fascia Iliaca compartment Block","NOT_YET_RECRUITING","2024-12-06",{"date":81,"type":82},"2024-12-11","ACTUAL",{"date":84,"type":67},"2025-01-01",{"date":86,"type":67},"2027-12-31",{"name":5,"class":6},1]